Findings in Fabry Disease Reported from Charles University and General University Hospital Prague (Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, ...)

Presse/Média: Research

Périodenov. 8 2023

Couverture média

1

Couverture média

  • TitreFindings in Fabry Disease Reported from Charles University and General University Hospital Prague (Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, ...)
    Nom du médiaClinical Trials Daily
    Pays/TerritoireUnited States
    Date11/8/23
    PersonnesMichael L. West